OriginalDrugs

Drug Guide

drugs

OriginalDrugs.com, founded in 2002, is a free informational website about medications, natural health products, common illnesses and their treatment methods. This is not a drugstore and we do not sell anything.

We closely follow an important processes of drug patent expirations. From the consumer's point of view this means that new generic drugs come to the market. And it is a well-known fact that generics cost much less than their brand name equivalents so consumers pay significantly less for their treatment.

NEW on OriginalDrugs:

Patent Expirations - New Generic Drugs

The next two to four years are an important time frame. During this period many of the top selling drugs of the major pharmaceutical companies will go off patent. For example, here is a list of patents that expire during the next five months of 2012:

  • May
    • Allegra (Sanofi Aventis)
    • Plavix (Sanofi Aventis)
    • Lamisil (Novartis)
  • June
    • Atacand (AstraZeneca)
    • Paxil CR (GlaxoSmithKline)
    • Imitrex Spray (GlaxoSmithKline)
    • Neoral (Novartis)
    • Maxalt (Merck)
  • July
    • Meridia (Abbott Laboratories)
    • Evista (Eli Lilly)
    • Lamictal (GlaxoSmithKline)
  • August
    • Singulair (Merck)
    • Cardizem (Valeant International)
    • Zoloft (Pfizer)
    • Lunesta (Sunovion)
  • September
    • Tikosyn (Pfizer)
    • Diovan (Novartis)

Between 2012 and 2013 will expire patents of such top-selling drugs as Advair (GlaxoSmithKline), Diovan (Novartis), Lovenox (Sanofi-Aventis), Plavix (Bristol-Myers Squibb), Seroquel (AstraZeneca).

As we already stated, patent expirations mean that equivalents of these expensive medications will be offered significantly cheaper. This might be not accepted well by pharmaceutical companies, because they lose exclusive rights to sell their medications and as a result lose their profits. But for the patients this is quite an opposite, they won't need to spend a fortune on their treatments.

In some cases manufacturers of the drugs still protected by patents will be forced to lower their prices. For example, of the three popular ED drugs - Viagra, Levitra, and Cialis - Pfizer's Viagra is the first one that loses patent protection. When this happens and generic Viagra will be available, manufacturers of Levitra (Bayer Pharmaceuticals) and Cialis (Eli Lilly and Co) will need to lower their prices to stay competitive.